Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Recruiting

Phase 3

Progestin PatchStudy to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Sponsor:

Mylan Pharmaceuticals Inc

Code:

NCT06672016

Conditions

Female Contraception

Eligibility Criteria

Sex: Female

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Transdermal system containing progestin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by Mylan Pharmaceuticals Inc on 2025-08-12.